EVRG vs STRO
Evergy, Inc. (EVRG) versus Sutro Biopharma (STRO) — a side-by-side from cached financials, not a winner call.
Evergy, Inc. (EVRG) is a utilities - regulated electric company listed on NASDAQ.
Sutro Biopharma (STRO) is a biotechnology company listed on NASDAQ.
Latest reported EVRG revenue for 2024-12-31 was $5.85B. Net income was $885.8M. Revenue was up 6.2% from 2023-12-31 to 2024-12-31. EVRG currently screens at market cap $19.10B and trailing P/E 22.0.
Latest reported STRO revenue for 2024-12-31 was $62.0M. Net income was -$227.5M. Revenue was down 59.6% from 2023-12-31 to 2024-12-31. STRO currently screens at market cap $470.8M.
EVRG currently screens at market cap $19.10B and trailing P/E 22.0. STRO currently screens at market cap $470.8M.
Not investment advice. Open the EVRG and STRO stock pages for the full models.
Not investment advice.